RPG Life Sciences Q4 Results
- BSE: 532983
- NSE: RPGLIFE
- ISIN: INE105J01010
- Sector: Biotechnology & Drugs
BSE
2,635.95
-8.00 (-0.30%)
-8.00 (-0.30%)Volume202.00
Updated: Tue 11 Aug, 2026 | 13:23:20
NSE
2,636.40-1.60 (-0.06%)
-1.60 (-0.06%)Volume2.96 K
Updated: Tue 11 Aug, 2026 | 13:26:23
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - RPG Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 148.70 | 154.07 | -3.49% | 110.76 | 1037.72% |
| Depreciation/ Amortization | 5.74 | 5.38 | 6.69% | 4.49 | 6.89% |
| Operating Income | 28.19 | 25.96 | 8.59% | 16.23 | -78.32% |
| Net Income | 29.90 | 22.13 | 35.11% | 13.24 | -74.52% |
| Other Operating Expenses Total | 47.17 | 40.05 | 17.78% | 30.05 | 26.53% |
| Net Income Before Taxes | 40.20 | 29.12 | 38.05% | 17.74 | -70.20% |
| Total Revenue | 176.89 | 180.03 | -1.74% | 126.99 | 23.62% |
| Selling/ General/ Admin Expenses Total | 36.30 | 35.32 | 2.77% | 34.78 | 14.87% |
| Diluted Normalized EPS | 17.58 | 17.25 | 1.92% | 8.00 | 33.71% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.